NashBio’s Post

DATA for AI Another super exciting discussion topic during #BioTechX USA  was Inter-Atlantic AI collaboration. As we all know the new EU AI Act puts extensive requirements on how sensitive data may be utilized in training and validation of AI models. This is nicely described e.g. on https://lnkd.in/gqxACUza In BioTechX USA we discussed the topic. It is not only tech giants that are concerned about the privacy risks, but high-compliance pharma companies and CROs obviously want to take it very seriously. A key take-home message is that the most secure possibility to avoid privacy risks in AI training and validation is to make data anonymous BEFORE it is taken into AI use. This is exactly what we are doing in some hospital, pharma and medtech projects. We anonymize data so that it can be used safely in AI purposes. Of course there still remains two questions to be answered. The first  comes from the legal department or compliance officers. They ask if the data truly is anonymous. This is a topic that we have elaborated  e.g. in @Findata projects. In practice we run a rich set of tests to verify that data actually passes given anonymity framework. Moreover, we perform a set of attack models to mimic the behavior of an attacker in order to give additional safeguards. The second question comes from the data end-users, data scientists and regulators. Anonymization and synthetization techniques “touch the data” - i.e. make modifications or maskings to the data. It is a fair question if the data is still representative and of high quality. For that purpose we have developed a data utility framework, where we actually run a rich protocol to make the data transformations and data utility implications both transparent and manageable. (A third interesting question comes from the regulators: as anonymization techniques are (and should be) irreversible. Otherwise they are not anonymization but pseudonymization techniques, which are a much weaker form of privacy protection. However, e.g., in clinical trials there is a strong legacy of requiring full traceability of the data. I will write later about this interesting topic.)

One company optimizing protein conjugates, one company screening for optimal efficacy and therapeutic window of protein conjugates. Well played, #RESIBoston2024 #ADCs #startup #proteinconjugation

Hear from Dan Deardorf CEO of Glycologix, as he shares his insights on how pivotal InnoVenture Labs has been in helping his company #GoFurtherFaster!

🚀 We are thrilled to share that Ryght has been selected to join the prestigious 2024 BioTools Innovator cohort! 🎉 We are eager to collaborate with an ecosystem of talented partners, strategics, and industry leaders throughout this incredible accelerator program. Stay tuned for updates as we work together to bring efficiency solutions to the forefront of #clinicaltrials and #clinicalresearch. Discover more about the amazing technology and solutions from all the cohort companies in the official press release below. #IamAnInnovator #Biotech #TechBio #BTI #Diagnostics #BioTools #LifeScienceTools

Come say "Hi!" at BioTechX. Let's start a conversation about unlocking the value of your chromatography and analytical data by partnering with ZONTAL, who offers over 400 different parsers and integrations. #ZONTAL #FAIRDATA #BIOTECHX

Hold onto your lab coats, we just launched our new Bio-Tech R&D page on our website! 🥼✨ Join us on a journey through the realms of innovation, where data-driven discoveries and biotech brilliance collide. Check it out: https://lnkd.in/dbrerGJz #BioInnovators #BioTechBreakthroughs #RnDInnovation #DataRevolution #InnovateWithData #TechInBiotech #InnovationStation #Scieline #ScielineWebsite

💡💡💡it’s #SAPAGP ‘s pleasure to be a partner with InScienceWeTrust Community to co-organize the #BioVerseWebinar series. Please feel free to let us know what topics you would love to hear in the future by leaving your comment!

Struggling to get it all done before your launch?! ImpactBio is here to support you every step of the way! Let us show you how we can help - connect with us today before another day goes by! #newproductlaunch #pharmalaunch #launchexcellence #commerciallaunchteam

𝐈𝐧𝐬𝐢𝐌𝐢𝐧𝐞 𝐚𝐭 𝐁𝐢𝐨𝐓𝐞𝐜𝐡𝐗!   Stop by InsiMine booth #S13 today and tomorrow at BioTechX USA in Philadelphia to understand how we can support pharma and biotech companies in strategically elevating their business operations through AI-driven, informed decision-making.   Looking forward to connecting with the attendees!   #BioTechXUSA2024 #generativeAI #healthcareAI

𝐀𝐭𝐭𝐞𝐧𝐝𝐢𝐧𝐠 𝐁𝐢𝐨𝐓𝐞𝐜𝐡𝐗 𝐔𝐒𝐀 𝐢𝐧 𝐏𝐡𝐢𝐥𝐚𝐝𝐞𝐥𝐩𝐡𝐢𝐚? Meet our leaders 𝐃𝐞𝐞𝐩𝐭𝐢 𝐓𝐚𝐲𝐚𝐥, 𝐏𝐡𝐃, and 𝐀𝐣𝐢𝐧𝐤𝐲𝐚 𝐒𝐚𝐬𝐞, 𝐏𝐡.𝐃., to explore how InsiMine's tailored, data-driven solutions can drive your biotech innovations forward. Discover insights and strategies that deliver real impact. #BioTechXUSA #insimine